PHASE II EVALUATION OF MR-GUIDED LASERINDUCED INTERSTITIAL THERMAL THERAPY (LITT) FOR PROSTATE CANCER
I. To evaluate the oncologic efficacy of laster interstitial thermal therapy (LITT) with
primary endpoint of undetectable cancer on magnetic resonance imaging (MRI)-guided biopsy of
treatment zone at 3 months following treatment.
I. To evaluate oncologic efficacy at 12 months following treatment based on biopsy of the
II. To determine treatment-related safety and toxicity. III. To longitudinally assess
urinary and sexual function in the year following treatment.
Patients undergo MR-guided LITT.
After completion of study treatment, patients are followed up at 1, 3, and 12 months.
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Undetectable cancer on MRI-guided biopsy of ablation zone following treatment
At 3 months
University of Chicago Comprehensive Cancer Center
United States: Institutional Review Board
|University of Chicago Comprehensive Cancer Center||Chicago, Illinois 60637-1470|